Cagent vascular appoints paul wilson as chief commercial officer to drive growth and market expansion

Wayne, penn.--(business wire)-- #cli--cagent vascular, inc., the exclusive developer of serration technology for vessel dilation in endovascular interventions, today announced the appointment of paul wilson as chief commercial officer (cco). in this role, mr. wilson will lead the company's commercial strategy, overseeing sales, marketing, clinical programming, and business development initiatives. his leadership will help expand awareness, accelerate growth, and strengthen market positioning of cagent.
ABT Ratings Summary
ABT Quant Ranking